A BRITISH start-up is looking to capitalise on t he accelerating ‘green rush’ into cannabis investment.

Grow was founded by former J PM organ banker Ben Langley in 2017 and has become an established importer of medicinal cannabis.

The biopharma firm has already raised £9.5 million to expand its operations through several fundraising rounds, and is now seeking £3.2 million via crowdfunding platform Seedrs.

Langley hopes to expand in the UK – where Grow reckons it has captured about 20 per cent of the burgeoning market – as well as on the Continent, and says it will invest in further research.

Sources say plans are already afoot f or a stock market flotation in the first half of next year.